LAWSUITS NEWS & LEGAL INFORMATION
Search Results for
Sort by relevance 140 pages found matching zyprexa- J&J Agrees $158M Settlement in Risperdal Lawsuit
New York, NY: Johnson & Johnson (J&J) has agreed to pay $158 million to settle a lawsuit in Texas suit that alleges the company defrauded the state by misleading doctors about its antipsychotic drug Risperdal. The deal will reportedly bring an end to claims that J&J marketed Risperdal off label - for unapproved uses - and downplayed... - GSK To Pay $3 Billion to Settle Avandia Claims
Nov-3-11 Washington, DC A $3 billion settlement has been reached between GlaxoSmithKline, the maker of the controversial diabetes medication Avandia, and federal authorities, ending investigations into whether or not the company marketed drugs for unapproved uses, among other charges. According to media reports, the GSK settlement tops the $2.3 million paid... - Antipsychotic Drugs - Side Effects of Antipsychotics, Antipsychotic Medications
A warning has been issued by the US Food and Drug Administration (FDA) concerning antipsychotic drugs and their use in pregnancy. According to the FDA, use of antipsychotics in pregnancy can result in harm to the fetus. Antipsychotic medications , which are used to treat the symptoms of psychiatric disorders such as schizophrenia, include medications s... - FDA Updates Pregnancy Section Labeling for Antipsychotic Drugs
Washington, DC: The FDA has notified healthcare professionals that the pregnancy section of drug labels for the entire class of antipsychotic drugs has been updated. The new drug labels now contain more and consistent information about the potential risk for abnormal muscle movements (extrapyramidal signs or EPS) and withdrawal symptoms in newborns w... - Canadian Attorney Files DePuy Class Action
Jan-11-11 Toronto, Ontario In early December 2010, Colin Stevenson of Stevensons LLP, a Canadian law firm based in Toronto, filed a products liability class-action lawsuit against Johnson & Johnson and its DePuy Orthopaedics subsidiary. Mr. Stevenson discusses the Canadian Depuy lawsuit with LawyersandSettlements. Q: (LawyersandSettlements) This Canadi... - Better than Byetta?
Sep-14-10 Washington, DC Do pharmaceutical companies make drugs to make us well, or simply to make money? Eli Lilly and Co. is currently waiting for a Food and Drug Administration (FDA) decision on a longer-acting version of its diabetes drug Byetta , which it partners on with Amylin Pharmaceuticals Inc. The patent for Byetta expires in 2013, according to a Ci... - A Potential New Market for Byetta?
Aug-18-10 Cincinatti, OH Type 2 diabetes drug Byetta , thought to be associated with acute pancreatitis and various other side effects, may one day put at risk an even wider range of patients. That's because an injectable form of Byetta is being considered for the treatment of a side effect caused by another drug. Zyprexa (olanzapine), a drug used to treat bi... - Whistleblowers Reap Rewards from Qui Tam Lawsuits
Jun-9-10 Washington, DC Recently, a number of pharmaceutical representatives have reaped huge rewards from qui tam whistleblower lawsuits. There are financial incentives for both good and bad pharmaceutical representatives—some manufacturers encourage and reward their (bad) reps with big bonuses if they promote drugs off-label—but selling drugs off-... - Qui Tam Whistleblower Off-label Pharma Suits on the Rise
May-14-10 Washington, DC Pharmaceutical and medical device companies are likely rethinking their fraudulent marketing plans, thanks to a number of successful qui tam off-label lawsuits that have cost pharma companies billions of dollars and reaped substantial awards for whistleblowers. Off-label use of a drug or device is a use other than that for which the p... - Diabetes y aumento de peso por Zyprexa
Zyprexa (olanzapina) es un medicamento recetado para el tratamiento de la esquizofrenia y la manía bipolar y se lo ha vinculado a la diabetes mellitus, la hiperglucemia, la pancreatitis y a trastornos de azúcar en sangre. Se han informado 288 casos de diabetes en pacientes a los que se administró Zyprexa; 23 de ellos resultaron fatales... - Zyprexa, Abilify, Risperdal, and Seroquel Cause Rapid Weight Gain in Children
The four top selling atypical antipsychotic medications used to treat schizophrenia and bipolar disorder have been linked to rapid and dangerous weight gain in children. Results from an 11-week study done in 272 children aged between 4 and 19 years were published today in JAMA, the official journal of the American Medical Association. The four drugs u... - Eli Lilly Settles Zyprexa Lawsuit in Connecticut
Eli Lilly and Co. has agreed to pay the state $25.1 million to settle a lawsuit alleging that the drug company marketed its antipsychotic drug Zyprexa for unapproved uses and did not adequately reveal the drug's side effects for more than 10 years. Connecticut State Attorney General Richard Blumenthal sued Eli Lilly last year, alleging that Lilly's... - Lilly Settles Zyprexa Lawsuits with 8 of 12 Remaining States
Eight of 12 states that sued Eli Lily & Co over alleged off-label promotion of its antipsychotic drug Zyprexa have reached a settlement with the pharmaceutical company. While the terms of the settlements are confidential, West Virginia's settlement is reportedly worth $2.5 million. Thirty-three other states have already settled their cons... - Malpractice at Nursing Home Results in $125K Settlement
A resident of the Green Acres nursing home in Wyndmoor, PA, who was overdosed on Zyprexa for 2 days, has been awarded a $125 K settlement. The suit centered on a miscommunication between a Dr. Aguirre, who said he prescribed 2.5 mg of Zyprexa over the phone to the nurse, and the nurse who claims he prescribed 25 mg of the drug. The resident w... - Hydroxycut Litigation Starts Packing On Heavyweight Attorneys
May-29-09 Hackensack, NJ: Balkin & Eisbrouch have been hammering away in the mass torts field for more than a decade and it shows. The list of dangerous drugs alone that David Eisbrouch has worked on literally goes from A to Z. From Accutane to Zyprexa, Eisbrouch has represented hundreds, if not thousands of people and won significant awards on behalf his clients. A... - Psychiatric Drugging of Children Intolerable-Betrayal of Innocence
Mar-8-09 Washington, DC The following is the third and final article in the series Psychiatric Drugging of Children . Part 2 explains how a -year-old girl named Rebecca Riley died of an overdose after being diagnosed with ADHD and bipolar disorder by Dr Kayoko Kifuji, at Tufts New England Medical Center in Boston, and placed on a three-drug cocktail.... Reb... - Psychiatric Drugging of Children Intolerable--Part 1
Feb-19-09 Washington, DC: Last September, the Law Project for Psychiatric Rights filed what is sure to become a landmark case against the State of Alaska aimed at stopping the over-prescribing of psychiatric drugs to children covered by public health care programs in that state. "The massive over-drugging of America's youth is an unfolding national horror," sa... - Eli Lilly Set to Accept $1.4 Billion Whistleblower Settlement
Jan-18-09 Washington, DC To say that a whistleblower cost a major pharmaceutical company $1.4 billion detracts from the value of whistle blowing as a major support protecting the safety and interests of consumers. How else might we have known about the alleged wrongdoings of Big Pharma giant Eli Lilly with regard to the marketing of Zyprexa? Whistleblowers perform... - Zyprexa Settlement Costs Lilly $1.4 Billion
A settlement has finally been reached between drug maker Eli Lilly and the Department of Justice, over allegations of overzealous marketing of its antipsychotic medication Zyprexa . Lilly will pay a reported $1.4 billion to settle the claims, and plead guilty to a misdemeanour violation of the Food, Drug and Cosmetic Act. The settlement of crimina... - Mother's Act Promotes Pregnancy as New Cottage Industry
Dec-5-08 Women of childbearing years represent the most lucrative market for the makers of psychiatric drugs. The knowledge that infants were being born with birth defects and suffering a withdrawal syndrome when these drugs were used during pregnancy was hidden for decades. Knowledge of these terrible risks would have caused a major drop in sales to this customer b...